Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Focal adhesion | R-HSA-354113 | map04510 | bupropion | 444 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | bupropion | 444 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | bupropion | 444 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | bupropion | 444 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | bupropion | 444 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | bupropion | 444 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | bupropion | 444 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | bupropion | 444 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | bupropion | 444 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | novobiocin | 2467 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | novobiocin | 2467 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | novobiocin | 2467 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | novobiocin | 2467 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | novobiocin | 2467 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | novobiocin | 2467 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | novobiocin | 2467 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | novobiocin | 2467 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | novobiocin | 2467 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | novobiocin | 2467 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | novobiocin | 2467 | drug-path |